Evidence map›Paper›PMID 31323433›Full record

ReviewBiochimica et biophysica acta. Gene regulatory mechanisms

Repeat-associated RNA structure and aberrant splicing.

Melissa A Hale, Nicholas E Johnson, J Andrew Berglund

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta. Gene regulatory mechanisms. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. SpecificMolecular therapy. Nucleic acids · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melissa A HaleDepartment of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Nicholas E JohnsonDepartment of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.
J Andrew BerglundThe RNA Institute, Department of Biological Sciences, University at Albany, State University of New York, Albany, NY 12222, USA. Electronic address: aberglund@albany.edu.
Virginia Commonwealth University · USAlbany State University · US

Funding

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research CenterP50NS048843 · NINDS · UNIVERSITY OF ROCHESTER · PI THORNTON, CHARLES A · 2018 to 2022
$7.1M
Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal)R01NS104010 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Nicholas Elwood Johnson · 2018 to 2026
$4.4M
Determining the factors that control dose-dependent splicing regulation by a master regulatorR01GM121862 · NIGMS · UNIVERSITY OF FLORIDA · PI BERGLUND, ANDREW, SPITALE, ROBERT C · 2017 to 2020
$2.0M
NIGMS NIH HHS R01 GM121862NINDS NIH HHS P50 NS048843NINDS NIH HHS R01 NS104010
6 · The paper itself

Abstract

Over 30 hereditary disorders attributed to the expansion of microsatellite repeats have been identified. Despite variant nucleotide content, number of consecutive repeats, and different locations in the genome, many of these diseases have pathogenic RNA gain-of-function mechanisms. The repeat-containing RNAs can form structures in vitro predicted to contribute to the disease through assembly of intracellular RNA aggregates termed foci. The expanded repeat RNAs within these foci sequester RNA binding proteins (RBPs) with important roles in the regulation of RNA metabolism, most notably alternative splicing (AS). These deleterious interactions lead to downstream alterations in transcriptome-wide AS directly linked with disease symptoms. This review summarizes existing knowledge about the association between the repeat RNA structures and RBPs as well as the resulting aberrant AS patterns, specifically in the context of myotonic dystrophy. The connection between toxic, structured RNAs and dysregulation of AS in other repeat expansion diseases is also discussed. This article is part of a Special Issue entitled: RNA structure and splicing regulation edited by Francisco Baralle, Ravindra Singh and Stefan Stamm.

Indexed as

Alternative SplicingGene Expression RegulationGenetic Predisposition to DiseaseHumansNucleic Acid ConformationRNARNA-Binding ProteinsTandem Repeat SequencesRNARNA-Binding ProteinsAlternative splicingMuscleblind-like (MBNL)Myotonic dystrophyRepeat expansion diseasesRNA binding proteinsRNA structure

Identifiers

PMID31323433
PMCPMC7099610
OpenAlexW2961201476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.